Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...

India's future is being shaped by a new wave of innovative companies revolutionizing industries through technology, ...

India’s pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

The Nifty Pharma Index has taken a hit, dropping nearly 2% in Friday’s trade. Over the last five days, the index has declined by approximately 4.3%, and on a year-to-date basis, it has fallen by ...

The Indian Pharmaceuticals Market continued to deliver healthy growth at 8.7% year-on-year in January 2025, against 7.7% year ...

While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors ...

Today, majors across segments including Parle Industries, Easy Trip Planners, Bajaj Consumer Care, Aditya Birla Fashion & ...

Several companies, including Oil India, HAL, Bharat Forge, Gillette India, KPI Green Energy, and Procter & Gamble Health, ...